Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impaired Insulin Regulation Determining Severity of Severe Acute Respiratory Syndrome COVID-19 Infection Confounded by Ethnicity

NCT05897528 is registered in ClinicalTrials.gov with Arrowhead Regional Medical Center as lead sponsor.

NCT NCT05897528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impaired Insulin Regulation Determining Severity of Severe Acute Respiratory Syndrome COVID-19 Infection Confounded by Ethnicity
Lead sponsor
Arrowhead Regional Medical Center
Phase
Observational
Overall status
Completed
Start date
October 14, 2021
Completion date
December 30, 2022
Enrollment
589 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, covid-19 pneumonia, covid-19 respiratory infection, diabetes mellitus